4.6 Review

Molecular pathology of endometrial carcinoma

Journal

HISTOPATHOLOGY
Volume 62, Issue 1, Pages 111-123

Publisher

WILEY
DOI: 10.1111/his.12053

Keywords

apoptosis; beta-catenin; chromosomal instability; E-cadherin; endometrial carcinoma; K-RAS; microsatellite instability; molecular genetics; PTEN; PIK3CA; TP53

Funding

  1. Fundacion Mutua Madrilena [AP75732010, 2009SGR794]
  2. RTICC [RD06/0020/1034, RD06/0020/0015]
  3. Fundacion Asociacion Espanola contra el Cancer
  4. programa de intensificacion de la investigacion, Instituto Carlos III, Department of Health, Spain
  5. [FIS PI100922]
  6. [FIS PI11-01561]

Ask authors/readers for more resources

Matias-Guiu X, & Prat J (2013) Histopathology 62, 111-123 Molecular pathology of endometrial carcinoma This review paper discusses the main molecular alterations of endometrial carcinoma, the most common cancer of the female genital tract. Two clinicopathological variants are recognized: the oestrogen-related (type I, endometrioid carcinoma) and the non-oestrogen-related (type II, non-endometrioid carcinoma). Whereas type I shows microsatellite instability and mutations in PTEN, PIK3CA, K-RAS and CTNNB1 (beta-catenin), type II exhibits TP53 mutations and chromosomal instability. Recent investigations regarding the role of non-coding RNA have provided important information regarding tumour progression. Understanding pathogenesis at the molecular level is essential for identifying biomarkers of potential use in targeted therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available